M. D. Wissel

Allele-specific cancer cell killing in vitro and in vivo targeting a single-nucleotide polymorphism in POLR2A

F. Baas, K. Fluiter, O. Mook, 2009, Cancer Gene Therapy.

Copy number variation upstream of PMP22 in Charcot–Marie–Tooth disease

F. Ruissen, F. Baas, J. Samijn, 2010, European Journal of Human Genetics.

TSEN54 mutations cause pontocerebellar hypoplasia type 5

F. Ruissen, F. Baas, D. Chitayat, 2011, European Journal of Human Genetics.

LRSAM 1-mediated ubiquitylation is disrupted in axonal Charcot – Marie – Tooth disease 2 P

F. Ruissen, F. Baas, N. Zelcer, 2017 .

Systemic inhibition of the membrane attack complex impedes neuroinflammation in chronic relapsing experimental autoimmune encephalomyelitis

F. Baas, T. Woodruff, C. van Kooten, 2018, Acta Neuropathologica Communications.

Recessive MYL2 mutations cause infantile type I muscle fibre disease and cardiomyopathy.

F. Baas, E. Aronica, C. Angelini, 2013, Brain : a journal of neurology.

UvA-DARE ( Digital Academic Repository ) In vivo tumor growth inhibition and biodistribution studies of locked nucleic acid ( LNA ) antisense oligonucleotides

Frank Baas, F. Baas, H. Olsson, 2017 .